JP2020011967A5 - - Google Patents

Download PDF

Info

Publication number
JP2020011967A5
JP2020011967A5 JP2019159348A JP2019159348A JP2020011967A5 JP 2020011967 A5 JP2020011967 A5 JP 2020011967A5 JP 2019159348 A JP2019159348 A JP 2019159348A JP 2019159348 A JP2019159348 A JP 2019159348A JP 2020011967 A5 JP2020011967 A5 JP 2020011967A5
Authority
JP
Japan
Prior art keywords
preparation according
external preparation
permeation
acid
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019159348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020011967A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020011967A publication Critical patent/JP2020011967A/ja
Publication of JP2020011967A5 publication Critical patent/JP2020011967A5/ja
Pending legal-status Critical Current

Links

JP2019159348A 2017-10-30 2019-09-02 爪白癬治療用の外用製剤 Pending JP2020011967A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017209136 2017-10-30
JP2017209136 2017-10-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019529667A Division JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤

Publications (2)

Publication Number Publication Date
JP2020011967A JP2020011967A (ja) 2020-01-23
JP2020011967A5 true JP2020011967A5 (enExample) 2021-12-02

Family

ID=66333195

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529667A Active JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤
JP2019159348A Pending JP2020011967A (ja) 2017-10-30 2019-09-02 爪白癬治療用の外用製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019529667A Active JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤

Country Status (14)

Country Link
US (1) US20210213002A1 (enExample)
EP (1) EP3705136A4 (enExample)
JP (2) JP6582158B1 (enExample)
KR (1) KR20200081432A (enExample)
CN (1) CN111295202B (enExample)
AU (1) AU2018358372A1 (enExample)
BR (1) BR112020008282A2 (enExample)
CA (1) CA3081163A1 (enExample)
IL (1) IL274100B2 (enExample)
MX (1) MX2020004491A (enExample)
RU (1) RU2020117569A (enExample)
SG (1) SG11202003820VA (enExample)
TW (1) TWI789448B (enExample)
WO (1) WO2019088005A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021132348A1 (ja) 2019-12-24 2021-07-01 科研製薬株式会社 エフィナコナゾールを含有する医薬
KR102217617B1 (ko) * 2020-08-14 2021-02-19 비엘엔에이치 주식회사 백선의 예방 또는 치료용 약학적 조성물
JP2022547755A (ja) * 2020-08-14 2022-11-16 ビーエルアンドエイチ カンパニー,リミテッド 白癬を防止又は処置するための医薬組成物
CA3203975A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
CA3216359A1 (en) 2021-04-07 2022-10-13 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
AU2023271525A1 (en) 2022-05-16 2024-12-05 Maruho Co., Ltd. Composition for treating ringworm
CN121772922A (zh) * 2023-08-02 2026-03-31 石原产业株式会社 甲癣用外用剂
AU2024353375A1 (en) 2023-09-29 2026-04-09 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions
JPS58162514A (ja) * 1982-03-19 1983-09-27 Sumitomo Chem Co Ltd 外用ゲル製剤
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
JP3688293B2 (ja) * 1993-09-29 2005-08-24 アルザ・コーポレーション モノグリセリド/乳酸エステル透過促進剤
JP5170486B2 (ja) * 1998-09-10 2013-03-27 バイオイコール ア−ゲー 局所適用性産物
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
JP5061519B2 (ja) 2006-07-12 2012-10-31 大正製薬株式会社 抗真菌剤含有o/wエマルション組成物
PL2191825T3 (pl) 2007-08-27 2016-11-30 Środek przeciwko grzybiczemu zapaleniu skóry
NL2003711C2 (en) * 2009-10-27 2011-04-28 Shield Mark B V Aqueous composition for topical application, method of preparation, uses and device.
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
KR101463707B1 (ko) 2011-01-30 2014-11-19 메이지 세이카 파루마 가부시키가이샤 외용 항진균제
PH12014501000A1 (en) * 2011-11-04 2014-06-09 Agile Therapeutics Inc Dermal delivery compositions and methods
RU2621615C2 (ru) * 2012-09-14 2017-06-06 Пола Фарма Инк. Фармацевтическая композиция, содержащая луликоназол
RU2694758C2 (ru) * 2012-12-20 2019-07-16 Раджив Бхушан Антимикробные композиции
TW201438742A (zh) * 2012-12-28 2014-10-16 大正製藥股份有限公司 皮膚適用製劑
CN103142458B (zh) * 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
JP6611014B2 (ja) * 2013-11-22 2019-11-27 ボシュ ヘルス アイルランド リミテッド 抗感染方法、抗感染組成物、および抗感染装置
JP5623671B1 (ja) * 2014-07-23 2014-11-12 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
SG11201801856XA (en) * 2015-09-18 2018-04-27 Kaken Pharmaceutical Co Ltd Biaryl derivative and medicine containing same
JP2017209136A (ja) 2016-05-23 2017-11-30 澁谷工業株式会社 電子線殺菌装置

Similar Documents

Publication Publication Date Title
JP2020011967A5 (enExample)
US8268876B2 (en) Pharmaceutical composition for external use
US8349882B2 (en) Pharmaceutical composition for external use
DK2315581T3 (en) TOPICAL COMPOSITION FOR THE TREATMENT OF actinic keratosis
JP2019108388A5 (enExample)
TWI789448B (zh) 灰指甲治療用之外用製劑
DK2190425T3 (en) Topically applicable fungicidal agents for the treatment of nails
JP2018526325A5 (enExample)
JP5883886B2 (ja) 抗真菌組成物
JP2012521351A (ja) 脂肪酸モノグリセリド組成物
WO2019164984A1 (en) Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibiotics
JP2024544415A5 (enExample)
JP2010519288A5 (enExample)
RU2017129893A (ru) Фармацевтическая композиция для местного применения
US10258560B1 (en) Composition for topical treatment of nail conditions
JP2016507540A (ja) 爪真菌症を治療するための局所用抗真菌薬組成物
JP2022516859A5 (enExample)
JP2008534644A5 (ja) 2型糖尿病を治療または予防する組成物
JP5816881B2 (ja) 核酸を有効成分とする外用剤組成物
RU2015129081A (ru) Гелевые композиции
WO2009087005A4 (en) Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
NZ797565B2 (en) 1-amino-1-cyclopropanecarboxylic acid hydrochloride formulations
JP2019043853A (ja) 経皮吸収促進剤、経皮吸収促進助剤、及び経皮製剤
JP2015134738A (ja) 皮膚真菌症治療剤